RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Feature ArticlesFeature Articles

    Spain Reimbursement Profile

    This profile summarizes the reimbursement process in Spain, presents key stakeholders and highlights what should be considered early in the development process. Obtaining regulatory approval for medicines is the first major hurdle of most pharmaceutical and biotechnology companies looking to launch their products worldwide. However, obtaining market access once products are authorized by regulatory agencies (e.g., AEMPS) is a separate and crucial process without which ...
  • Feature ArticlesFeature Articles

    France Reimbursement Profile

    This profile summarizes the reimbursement process, presents key stakeholders in France and highlights complexities to be considered early in the development process. Introduction Obtaining regulatory approval for medicines is the first major hurdle of most pharmaceutical and biotechnology companies looking to launch their products worldwide. However, obtaining market access once products are approved by regulatory agencies, such as Haute Autorité de la Santé (HAS), is...